Surveillance of HIV, Hepatitis B and Hepatitis C, and related (risk) behavior among hard drug users under addictive care at Mondriaan centre in Heerle

Withdrawn

• Conditions: AIDS; Hepatitis; HIV; infectious diseases; jaundice; 10021460; 10047438; 10024450

• Registration Number: NL-OMON33271
• Lead Sponsor: RIVM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 6 May 2024

Recruitment & Eligibility

• Status: Withdrawn
• Sex: Not specified
• Target Recruitment: 100

Inclusion Criteria

- Individuals aged 18 and above
- Individuals who are under care at Mondriaan outpatient clinic for drug addicts in Heerlen
- Individuals who have used hard drugs at least once a week throughout the last 6 months. Hard drugs are defined as heroin, coke, opium, methadone, LSD, amphetamine (speed), or XTC
- Both injecting and non-injecting hard drug users
- Individuals with a signed written informed consent for participation in the study

Exclusion Criteria

- Individuals under the age of 18 years
- Individuals without written informed consent
- Individuals who have participated in the study before
- Individuals who have not used hard drugs more than once a week throughout the last 6 months

Study & Design

• Study Type: Observational non invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>The primary outcome of interest is to assess in the prevalence of viral<br /><br>infectious diseases (HIV, hepatitis C and hepatitis B) among hard drug users in<br /><br>care at Mondriaan carecentre for addiction in Heerlen. </p><br>

Secondary Outcome Measures

Name	Time	Method
<p>Secondary outcomes encloses understanding of potential associations for<br /><br>infectious diseases, and (related) risk factors like drug and sexual behavior,<br /><br>demographics, mobility of addicts, detention, sexual transmitted diseases and<br /><br>the use of Methadone. </p><br>